Experimental Vaccine for Prevention of Ebola Virus Infection

NCT00374309 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

NIH

Sponsor class

Conditions

Ebola Hemorrhagic Fever
Ebola Virus Disease
Ebola Virus Vaccines
Envelope Glycoprotein, Ebola Virus
Filovirus

Interventions

DRUG: VRC-EBOADV018-00-VP

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)